The development of an automated and GMP compliant FASTlab™ Synthesis of [18F]GE‐180; a radiotracer for imaging translocator protein (TSPO)
- 23 September 2013
- journal article
- protocols and-methods
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 57 (1), 42-48
- https://doi.org/10.1002/jlcr.3112
Abstract
The level of the translocator protein (TSPO) increases dramatically in microglial cells when the cells are activated in response to neuronal injury and insult. The radiotracer [18F]GE-180 binds selectively and with high affinity to TSPO and can therefore be used to measure neuroinflammation in a variety of disease states. An optimized, automated synthesis of [18F]GE-180 has been developed for the GE FASTlab™ synthesizer. The entire process takes place on the single-use cassette. The radiolabelling is performed by nucleophilic fluorination of the S- enantiomer mesylate precursor. The crude product is purified post-radiolabelling using two solid-phase extraction cartridges integrated on the cassette. Experimental design and multivariate data analysis were used to assess the robustness, and critical steps were optimized with respect to efficacy and quality. The average radiochemical yield is 48% (RSD 6%, non-decay corrected), and the synthesis time including purification is approximately 43 min. The radiochemical purity is ≥95% for radioactive concentration ≤1100 MBq/mL. The total amount of precursor-related chemical impurities is 1–2 µg/mL. The use of solid-phase extraction purification results in a robust GMP compliant process with a product of high chemical and radiochemical purity and consistent performance across positron emission tomography (PET) centers.Keywords
This publication has 29 references indexed in Scilit:
- PET Imaging of Lung Inflammation with [18F]FEDAC, a Radioligand for Translocator Protein (18 kDa)PLOS ONE, 2012
- [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106—Selective radioligands for imaging TSPO 18kDa with PET: Automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controlsApplied Radiation and Isotopes, 2012
- The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivoEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)AcetamideJournal of Nuclear Medicine, 2012
- Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-PhenoxyanilineJournal of Nuclear Medicine, 2010
- Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in HumansJournal of Nuclear Medicine, 2009
- [11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes EncephalitisMolecular Imaging & Biology, 2009
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008
- Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptorsNeuroImage, 2008
- PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in ratNeuroscience Letters, 2007